• No results found

Therapeutic and imaging potential of peptide agents in cardiocascular disease

N/A
N/A
Protected

Academic year: 2021

Share "Therapeutic and imaging potential of peptide agents in cardiocascular disease"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Therapeutic and imaging potential of peptide agents in cardiocascular

disease

Yu, H.

Citation

Yu, H. (2007, June 21). Therapeutic and imaging potential of peptide agents in cardiocascular disease. Retrieved from https://hdl.handle.net/1887/12090

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

(2)

Therapeutic and Imaging Potential of

Peptide Agents in Cardiovascular Disease

(3)
(4)

Therapeutic and Imaging Potential of

Peptide Agents in Cardiovascular Disease

PROEFSCHRIFT ter verkrijging van

de graad van Doctor aan de Universiteit Leiden,

op gezag van de Rector Magnificus Prof. Mr. P.F.van der Heijden, hoogleraar in de faculteit der Wiskunde en

Natuurwetenschappen en die der Geneeskunde, volgens besluit van het College voor Promoties

te verdedigen op Donderdag 21 June 2007 klokke 13.45 uur

door

Haixiang Yu

geboren te Baotou, Inner Mongolia, China On Nov 26 1976

(5)

Promotiecommissie

Promotor: Prof. Dr. Erik. A.L. Biessen Prof. Dr. Theo. J. C. Van Berkel Referent: Dr. Leon de Windt

Overige leden: Prof. Dr. Meindert Danhof Prof. Dr. Herman Overkleeft

Dr. Sylvia Heeneman

The studies presented in this thesis were performed in the Division of Biopharmaceutics of the Leiden/Amsterdam Center for Drug Research (LACDR), Leiden University, the Netherlands

The study presented in this thesis was financially supported by the Dutch Technology Foundation STW project LFA.5952. Financial support by the STW for the publication of this thesis is gratefully acknowledged.

Financial support by the Netherlands Heart Foundation for the publication of this thesis is gratefully acknowledged

The printing of this thesis was also financially supported by -LACDR

-Tebu-bio BV -Corning BV

(6)

To my father Yu Shuhe, mother Yao Meiling and my wife Huang Yanchao

(7)

Cover: landscape of Leiden, the Netherlands, photographed by Haixiang Yu Printing by: Gildeprint Drukkerijen, Enschede, the Netherlands

ISBN/EAN: 978-90-9021922-6 Haixiang Yu

Therapeutic and Imaging Potential of Peptide Agents in Cardiovascular Disease

Proefschrift Leiden – Met lit. opgave – Met samenvatting in het Nederlands

© 2007 Haixiang Yu

No part of this thesis may be reproduced or transmitted in any form or by any means, without written permission of the author.

(8)

Table of Contents

Page Chapter 1 General introduction

9 Chapter 2 Therapeutic Potential of VIVIT, a Selective Peptide

Inhibitor of Nuclear Factor of Activated T cells, in Cardiovascular Disorders

33

Chapter 3 Atherosclerosis Imaging Potential of a Novel Peptide Ligand selective for SR-AI

47

Chapter 4 Targeting CD40 with a Selective Phage Display Derived Peptide

61

Chapter 5 Therapeutic Potential of a Synthetic Peptide Inhibitor of NFAT as Anti-restenotic Agent

75

Chapter 6 Potent Bipartite Inhibitors of Nuclear Factor of Activated T-Cells with Superior Selectivity Compared with Cyclosporin A

93

Chapter 7 General Discussion and Summary 115

Chapter 8 Nederlandse Samenvatting 123

Abbreviations 127

Publication list 129

Curriculum Vitae 131

Appendix-color figures 133

(9)

Referenties

GERELATEERDE DOCUMENTEN

Financial support by the Netherlands Heart Foundation and the Netherlands Organization of Scientific Research for the publication of this thesis is grate- fully acknowledged..

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded.

SR-AI, CD36 (SR class B), CD68 (SR class D), lectin-like oxidized LDL receptor (LOX-1, SR class E), scavenger receptors expressed by endothelial cells (SREC, SR class F), and

In search of antagonist specific for SR-AI, we have employed affinity selection of a random phage displayed peptide library on a synthetic receptor comprising the ligand

(C) Binding of the enriched phage pool to human CD40-muIgG was determined in the presence of synthetic peptides encoded by CD40 specific phage clone NP31 (); a scrambled NP31

While HPVIVIT and INCA12 both are weak inhibitors of calcineurin-NFAT interaction, simultaneous targeting of both NFAT recognition sites on calcineurin by MCV1 will result in

In this thesis, we aimed to develop novel peptide ligands by a combined phage display and bioorganic synthesis strategy and to investigate the targeted potential of developed

Financial support by the Dutch Heart Foundation for the publication of this thesis is gratefully acknowledged. Financial support for the accomplishment of this thesis by Alltech